1333 related articles for article (PubMed ID: 22161392)
1. Botulinum toxin injections for adults with overactive bladder syndrome.
Duthie JB; Vincent M; Herbison GP; Wilson DI; Wilson D
Cochrane Database Syst Rev; 2011 Dec; (12):CD005493. PubMed ID: 22161392
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin injections for adults with overactive bladder syndrome.
Duthie J; Wilson DI; Herbison GP; Wilson D
Cochrane Database Syst Rev; 2007 Jul; (3):CD005493. PubMed ID: 17636801
[TBL] [Abstract][Full Text] [Related]
3. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
[TBL] [Abstract][Full Text] [Related]
4. Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction.
Utomo E; Groen J; Blok BF
Cochrane Database Syst Rev; 2014 May; 2014(5):CD004927. PubMed ID: 24859260
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of intravesical botulinum toxin for idiopathic overactive bladder symptoms: a systematic review of the literature.
Anger JT; Weinberg A; Suttorp MJ; Litwin MS; Shekelle PG
J Urol; 2010 Jun; 183(6):2258-64. PubMed ID: 20400142
[TBL] [Abstract][Full Text] [Related]
6. Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults.
Rai BP; Cody JD; Alhasso A; Stewart L
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD003193. PubMed ID: 23235594
[TBL] [Abstract][Full Text] [Related]
7. [Botulinum toxin for overactive bladder].
Ziegelmüller BK; Sommer A; Bauer RM
Urologe A; 2020 Aug; 59(8):963-972. PubMed ID: 32691107
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin-A injections for idiopathic overactive bladder: a systematic review and meta-analysis.
Cui Y; Wang L; Liu L; Zeng F; Niu J; Qi L; Chen H
Urol Int; 2013; 91(4):429-38. PubMed ID: 23970316
[TBL] [Abstract][Full Text] [Related]
9. Electrical stimulation with non-implanted electrodes for overactive bladder in adults.
Stewart F; Gameiro LF; El Dib R; Gameiro MO; Kapoor A; Amaro JL
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010098. PubMed ID: 27935011
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes of intravesical injections of botulinum toxin type A in patients with refractory idiopathic overactive bladder.
Juszczak K; Adamczyk P; Maciukiewicz P; Drewa T
Pharmacol Rep; 2018 Dec; 70(6):1133-1138. PubMed ID: 30317128
[TBL] [Abstract][Full Text] [Related]
11. Objective and subjective improvement in children with idiopathic detrusor overactivity after intravesical botulinum toxin injection: A preliminary report.
Al Edwan GM; Mansi HH; Atta ONM; Shaath MM; Al Adwan R; Mahafza W; Afram KM; Ababneh O; Al Adwan D; Muheilan MM
J Pediatr Surg; 2019 Mar; 54(3):595-599. PubMed ID: 29887168
[TBL] [Abstract][Full Text] [Related]
12. Bladder instillation of liposome encapsulated onabotulinumtoxina improves overactive bladder symptoms: a prospective, multicenter, double-blind, randomized trial.
Chuang YC; Kaufmann JH; Chancellor DD; Chancellor MB; Kuo HC
J Urol; 2014 Dec; 192(6):1743-9. PubMed ID: 25046622
[TBL] [Abstract][Full Text] [Related]
13. [Botulinum toxin injection for refractory non-neurogenic overactive bladder. Systematic review].
Henriet B; Roumeguère T
Rev Med Brux; 2015; 36(1):29-37. PubMed ID: 25856969
[TBL] [Abstract][Full Text] [Related]
14. Electrical stimulation with non-implanted electrodes for overactive bladder in adults.
Stewart F; Gameiro OL; El Dib R; Gameiro MO; Kapoor A; Amaro JL
Cochrane Database Syst Rev; 2016 Apr; 4():CD010098. PubMed ID: 27037009
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin type B for cervical dystonia.
Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
Cochrane Database Syst Rev; 2005 Jan; (1):CD004315. PubMed ID: 15674941
[TBL] [Abstract][Full Text] [Related]
16. An indirect comparison meta-analysis of noninvasive intravesical instillation and intravesical injection of botulinum toxin-A in bladder disorders.
Yunfeng G; Fei L; Junbo L; Dingyuan Y; Chaoyou H
Int Urol Nephrol; 2022 Mar; 54(3):479-491. PubMed ID: 35044552
[TBL] [Abstract][Full Text] [Related]
17. Intravesical botulinum-A toxin in children with refractory non-neurogenic overactive bladder.
Lambregts AP; Nieuwhof-Leppink AJ; Klijn AJ; Schroeder RPJ
J Pediatr Urol; 2022 Jun; 18(3):351.e1-351.e8. PubMed ID: 35283021
[TBL] [Abstract][Full Text] [Related]
18. Oral anticholinergic drugs versus placebo or no treatment for managing overactive bladder syndrome in adults.
Stoniute A; Madhuvrata P; Still M; Barron-Millar E; Nabi G; Omar MI
Cochrane Database Syst Rev; 2023 May; 5(5):CD003781. PubMed ID: 37160401
[TBL] [Abstract][Full Text] [Related]
19. Sacral neuromodulation and intravesical botulinum toxin for refractory overactive bladder.
Kantartzis K; Shepherd J
Curr Opin Obstet Gynecol; 2012 Oct; 24(5):331-6. PubMed ID: 22922403
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of intravesical botulinum toxin-A injections in women with idiopathic overactive bladder symptoms.
Marcelissen TA; Rahnama'i MS; Snijkers A; Schurch B; De Vries P
World J Urol; 2017 Feb; 35(2):307-311. PubMed ID: 27272312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
